Search for: "Fade v. Morris"
Results 1 - 20
of 20
Sorted by Relevance
|
Sort by Date
20 Feb 2007, 7:44 am
Justice Thomas wrote the majority opinion in Lawrence v. [read post]
29 Jan 2008, 10:00 am
See Lamb v. [read post]
24 Jun 2022, 4:10 am
This rationale is referred to as the ‘Bonnick Principle’ following the 2002 Privy Council decision in Bonnick v Morris [2003] 1 AC 300. [read post]
19 May 2006, 3:14 am
Daniel Morris, -- F.3d --, No. 05-1623 (6th Cir. [read post]
23 Jun 2020, 1:01 pm
“As time passes, memories fade, documents are destroyed or lost, and witnesses disappear. [read post]
23 Jun 2020, 1:01 pm
“As time passes, memories fade, documents are destroyed or lost, and witnesses disappear. [read post]
5 Apr 2019, 7:53 am
In his 1897 report to the American Historical Association, Herman V. [read post]
5 Sep 2007, 7:39 am
The problem is magnified as the time period covered by the requests expands and, therefore, memories fade and persons with first-hand knowledge leave the company.These practical problems, however real, are virtually never acknowledged by courts (or their designees) resolving privilege claims. [read post]
4 Feb 2008, 11:20 am
King Billable Hour v. [read post]
11 Feb 2011, 7:51 am
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
30 May 2012, 1:37 pm
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
22 Jun 2011, 7:09 am
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
2 Oct 2010, 8:43 am
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
15 Feb 2012, 7:42 am
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:08 pm
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:07 pm
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
9 Sep 2011, 8:40 am
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:07 pm
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:08 pm
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
21 Jun 2011, 1:00 pm
The committee has included an understanding in the resolution of advice and consent that addresses this point (see section V below). [read post]
